Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
OtherPerspective
Open Access

Current status of multiple markers in precision immunotherapy for colorectal cancer

Chao Liu, Ya Lan, Hong Wang and Yanqiao Zhang
Cancer Biology & Medicine March 2025, 22 (3) 205-211; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0030
Chao Liu
1Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150000, China
2Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150000, China
3Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ya Lan
1Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150000, China
3Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Wang
1Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150000, China
3Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanqiao Zhang
1Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150000, China
2Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin 150000, China
3Key Laboratory of Tumor Immunology in Heilongjiang, Harbin 150000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yanqiao Zhang
  • For correspondence: yanqiaozhang{at}ems.hrbmu.edu.cn
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 22 no. 3 205-211
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2025.0030

Published By 
Cancer Biology & Medicine
History 
  • Received January 16, 2025
  • Accepted February 20, 2025
  • Published online April 8, 2025.

Article Versions

  • previous version (March 26, 2025 - 04:45).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright: © 2025 The Authors This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License.

Author Information

Funding

  • National Natural Science Foundation of China

    U22A20330
  • National Natural Science Foundation of China

    82373372
  • Key Project of Research and Development Plan in Heilongjiang Province

    2022ZX06C01
  • Key Project of Research and Development Plan in Heilongjiang Province

    JD2023SJ40
  • Natural Science Funding of Heilongjiang

    YQ2022H017
  • Haiyan Foundation of Harbin Medical University Cancer Hospital

    JJJQ 2024-02

This study was supported by grants from the National Natural Science Foundation of China (Nos. U22A20330 and 82373372), the Key Project of Research and Development Plan in Heilongjiang Province (Nos. 2022ZX06C01 and JD2023SJ40), the Natural Science Funding of Heilongjiang (No. YQ2022H017), and the Haiyan Foundation of Harbin Medical University Cancer Hospital (No. JJJQ 2024-02).

PreviousNext
Back to top

In this issue

Cancer Biology & Medicine: 22 (3)
Cancer Biology & Medicine
Vol. 22, Issue 3
15 Mar 2025
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Current status of multiple markers in precision immunotherapy for colorectal cancer
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Current status of multiple markers in precision immunotherapy for colorectal cancer
Chao Liu, Ya Lan, Hong Wang, Yanqiao Zhang
Cancer Biology & Medicine Mar 2025, 22 (3) 205-211; DOI: 10.20892/j.issn.2095-3941.2025.0030

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Current status of multiple markers in precision immunotherapy for colorectal cancer
Chao Liu, Ya Lan, Hong Wang, Yanqiao Zhang
Cancer Biology & Medicine Mar 2025, 22 (3) 205-211; DOI: 10.20892/j.issn.2095-3941.2025.0030
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Immune microenvironment characteristics across different pathologic CRC subtypes
    • Immunotherapy biomarkers in CRC
    • Precision immunotherapy in CRC
    • Conflicts of interest statement
    • Author contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Pan-KRAS inhibition: unlocking broad-spectrum targeted therapy for KRAS-mutant cancers
  • Rethinking anti-cancer drug discovery: the evolution from polypharmacy to unified drug units
  • From bone marrow to the tumor microenvironment: how neutrophil maturation shapes cancer immunity
Show more Perspective

Similar Articles

Subjects

  • Cancer immunology and immunotherapy
  • Gastrointestinal cancer

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire